ADAMAS looks forward to attending the upcoming DIA Global Annual Meeting 2024 that will take place in San Diego, CA from 16-20 June. The DIA 2024 Global Annual Meeting invites industry, regulators, governments, academics, innovators, and patients to network,...
ADAMAS is thrilled to announce our presence at the RQA 2023 International QA Conference, taking place from the 1st to the 3rd of November in Belfast. You can find us at Stand #18, where we're ready to connect, collaborate, and spark innovative discussions with...
At this moment the FDA Center for Devices and Radiological Health (CDRH), in collaboration with the Center for Biologics Evaluation and Research (CBER) and the Center for Drug Evaluation and Research (CDER), are planning to release a new guidance document entitled...
This piece is an extract of the upcoming ADAMAS white paper “Making the Model: Solving the Data Integrity Challenge of Decentralized Clinical Trials”. Data integrity is an essential element of any data handling task. It goes without saying that if data isn’t accurate...
No matter if you're preparing for an imminent clinical trial inspection or if you're just bracing for a mock inspection, it is vital for you and your team to be prepared. Even so, establishing a culture of readiness can be difficult with each step presenting its own...
ADAMAS’s commitment to upholding our values of clarity, integrity and excellence is made possible by the calibre of its people, and the knowledge and experience they bring. It is this expertise and assiduous work ethic that our employees appreciate the most about one...
It is because of our team of expert consultants with outstanding industry knowledge and exceptional client care that we are able to provide the highest caliber auditing services. Not only is the ADAMAS team composed of the most dedicated and experienced individuals in...
At ADAMAS we have made a commitment to all our clients to ensure safe, accurate and secure retention of critical information relating to the services we have provided. For example, the final version of audit reports as well as the CV and Training Record of the...
The Medicines and Healthcare products Regulatory Agency (MHRA) recently published their latest Good Pharmacovigilance Practice (GPvP) inspection metrics covering the period April 2018 to March 2019. Within this period a total of 18 inspections of Marketing...
Enhancing Good Pharmacovigilance Practice with ADAMAS Consulting
DIA 2024 Global Annual Meeting | San Diego, CA
Come and meet ADAMAS Consulting at the RQA European QA Conference, Belfast
Computer Software Assurance (CSA): Why the Change and What Does it Mean?
Annex 1 Revisions: What are the Changes and Whom will they Affect?